Published on:

FDA to Strengthen Warnings on Diabetes Medication following Two Deaths

The US Food and Drug Administration (FDA) is planning to strengthen the warnings on the diabetes drug Byetta after receiving reports of another 6 patients being admitted to the hospital. Two of these patients died because they got hemorrhagic or necrotizing pancreatitis after taking the drug. Byetta is a drug that is administered by injection for treating adults with type 2 diabetes. The total number of people that have fallen ill with pancreatitis after taking Byetta is 36. The FDA said that the there is “an association between Byetta and acute pancreatits is suspected in some of these cases.” However, most of the reported cases involved at least one other risk factor. The agency did say that it is not advising doctors to stop prescribing Byetta and will be posting further advice and alert updates if they receive anymore information. To read the full story, click here.